InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.70%
)
US TECH 100
18,318.00
(
0.95%
)
Dow Jones
39,069.59
(
0.01%
)
Brent Oil
81.97
(
0.00%
)
Bitcoin
69,170.00
(
-0.14%
)

Replies to post #2579 on PROTALIX BIOTHERAPEUTICS, INC. (PLX)

Replies to #2579 on PROTALIX BIOTHERAPEUTICS, INC. (PLX)

king oil

12/14/18 4:37 PM

#2580 RE: Tomix #2579

Why

king oil

12/17/18 11:57 AM

#2581 RE: Tomix #2579

Protalix BioTherapeutics Announces the Completion of Enrollment in the Phase III BRIDGE Clinical Trial of pegunigalsidase alfa for the Treatment of Fabry Disease

https://globenewswire.com/news-release/2018/12/17/1667809/0/en/Protalix-BioTherapeutics-Announces-the-Completion-of-Enrollment-in-the-Phase-III-BRIDGE-Clinical-Trial-of-pegunigalsidase-alfa-for-the-Treatment-of-Fabry-Disease.html